Suppr超能文献

伴有路易体病的法布里病。

Fabry Disease With Concomitant Lewy Body Disease.

机构信息

Clinical Neuroanatomy Section, Department of Neurology, Center for Biomedical Research, University of Ulm.

Department of Neurology, University of Ulm and DZNE.

出版信息

J Neuropathol Exp Neurol. 2020 Apr 1;79(4):378-392. doi: 10.1093/jnen/nlz139.

Abstract

Although Gaucher disease can be accompanied by Lewy pathology (LP) and extrapyramidal symptoms, it is unknown if LP exists in Fabry disease (FD), another progressive multisystem lysosomal storage disorder. We aimed to elucidate the distribution patterns of FD-related inclusions and LP in the brain of a 58-year-old cognitively unimpaired male FD patient suffering from predominant hypokinesia. Immunohistochemistry (CD77, α-synuclein, collagen IV) and neuropathological staging were performed on 100-µm sections. Tissue from the enteric or peripheral nervous system was unavailable. As controls, a second cognitively unimpaired 50-year-old male FD patient without LP or motor symptoms and 3 age-matched individuals were examined. Inclusion body pathology was semiquantitatively evaluated. Although Lewy neurites/bodies were not present in the 50-year-old individual or in controls, severe neuronal loss in the substantia nigra pars compacta and LP corresponding to neuropathological stage 4 of Parkinson disease was seen in the 58-year-old FD patient. Major cerebrovascular lesions and/or additional pathologies were absent in this individual. We conclude that Lewy body disease with parkinsonism can occur within the context of FD. Further studies determining the frequencies of both inclusion pathologies in large autopsy-controlled FD cohorts could help clarify the implications of both lesions for disease pathogenesis, potential spreading mechanisms, and therapeutic interventions.

摘要

虽然戈谢病可伴有路易体病理(LP)和锥体外系症状,但路易体是否存在于另一种进行性多系统溶酶体贮积病——法布里病(FD)中尚不清楚。我们旨在阐明脑内 FD 相关包涵体和 LP 的分布模式,研究对象为一名认知无障碍的 58 岁男性 FD 患者,其主要表现为运动迟缓。对 100µm 切片进行免疫组织化学(CD77、α-突触核蛋白、胶原 IV)和神经病理学分期检测。无法获得肠或周围神经系统的组织。作为对照,我们还检查了另一名认知无障碍的、无 LP 或运动症状的 50 岁男性 FD 患者和 3 名年龄匹配的个体。对包涵体病理进行半定量评估。尽管在 50 岁个体或对照者中未见路易神经突/体,但在 58 岁 FD 患者中,观察到黑质致密部严重神经元丧失和与帕金森病神经病理学分期 4 相对应的 LP。该个体中无重大脑血管病变和/或其他病变。我们的结论是,路易体病伴帕金森病可发生于 FD 中。进一步的研究确定在大型尸检对照 FD 队列中这两种包涵体病变的频率,可能有助于阐明这两种病变对疾病发病机制、潜在传播机制和治疗干预的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a408/7092358/8b25bdf65b5b/nlz139f1.jpg

相似文献

1
Fabry Disease With Concomitant Lewy Body Disease.
J Neuropathol Exp Neurol. 2020 Apr 1;79(4):378-392. doi: 10.1093/jnen/nlz139.
2
TIGAR inclusion pathology is specific for Lewy body diseases.
Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.
3
Formation and development of Lewy pathology: a critical update.
J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y.
4
Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
J Neurol Sci. 2002 Mar 30;195(2):153-9. doi: 10.1016/s0022-510x(02)00006-0.
6
Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
Mov Disord. 2012 Jan;27(1):8-30. doi: 10.1002/mds.23795. Epub 2011 Nov 11.
7
Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.
Acta Neuropathol. 2010 Nov;120(5):641-9. doi: 10.1007/s00401-010-0741-7. Epub 2010 Sep 14.
8
Regional Overlap of Pathologies in Lewy Body Disorders.
J Neuropathol Exp Neurol. 2017 Mar 1;76(3):216-224. doi: 10.1093/jnen/nlx002.

引用本文的文献

1
ASIC1a-associated mechanical hypersensitivity in the GlaKO Fabry disease mouse model.
Neurobiol Pain. 2025 Jun 26;18:100189. doi: 10.1016/j.ynpai.2025.100189. eCollection 2025 Jul-Dec.
4
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations.
Front Cardiovasc Med. 2024 Jan 24;11:1341590. doi: 10.3389/fcvm.2024.1341590. eCollection 2024.
5
Enzymatic properties and clinical associations of serum alpha-galactosidase A in Parkinson's disease.
Ann Clin Transl Neurol. 2023 Sep;10(9):1662-1672. doi: 10.1002/acn3.51856. Epub 2023 Jul 26.
6
Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse.
Int J Mol Sci. 2023 Mar 9;24(6):5246. doi: 10.3390/ijms24065246.
7
HomeCageScan analysis reveals ongoing pain in Fabry rats.
Neurobiol Pain. 2023 Jan 5;13:100113. doi: 10.1016/j.ynpai.2022.100113. eCollection 2023 Jan-Jul.
8
Anderson-Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
Biomedicines. 2022 Dec 5;10(12):3132. doi: 10.3390/biomedicines10123132.
9
Prevalence of Fabry Disease among Patients with Parkinson's Disease.
Parkinsons Dis. 2022 Jan 24;2022:1014950. doi: 10.1155/2022/1014950. eCollection 2022.

本文引用的文献

2
Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease.
Front Neurol. 2019 Oct 9;10:1053. doi: 10.3389/fneur.2019.01053. eCollection 2019.
4
Progress in the understanding and treatment of Fabry disease.
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129437. doi: 10.1016/j.bbagen.2019.129437. Epub 2019 Sep 14.
5
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.
Nat Neurosci. 2019 Jul;22(7):1099-1109. doi: 10.1038/s41593-019-0423-2. Epub 2019 Jun 24.
6
Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
Neurology. 2019 May 21;92(21):e2472-e2482. doi: 10.1212/WNL.0000000000007530. Epub 2019 Apr 24.
7
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons.
Acta Neuropathol. 2019 Jun;137(6):961-980. doi: 10.1007/s00401-019-01995-0. Epub 2019 Mar 29.
8
α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.
Acta Neuropathol. 2019 Jul;138(1):1-21. doi: 10.1007/s00401-019-01977-2. Epub 2019 Feb 23.
10
Lysosomal storage disorders affecting the heart: a review.
Cardiovasc Pathol. 2019 Mar-Apr;39:12-24. doi: 10.1016/j.carpath.2018.11.002. Epub 2018 Dec 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验